PCSK9 and cardiovascular disorder: In this context, it is noteworthy that Butt et al20 observed higher reduction of cardiovascular disease (CVD) events in DAA‐treated patients than in those treated with IFN‐containing regimens, which complements our observation that DAA treatment results in SVR in HCV‐infected patients and decreases serum levels of PCSK9.